Cargando…
Identification of Mutated Peptides in Bladder Cancer From Exomic Sequencing Data Reveals Negative Correlation Between Mutation-Specific Immunoreactivity and Inflammation
INTRODUCTION AND OBJECTIVE: Neoantigen-based immunotherapy is one of the breakthroughs in cancer immunotherapy. Benefit from the Cancer Genome Atlas database, we intended to identify mutant peptides with neoantigen property in bladder cancer (BC). Correlations between the immunoreactivity of candida...
Autores principales: | Wang, Chen, Ding, Yu, Liu, Yuanyong, Zhang, Qingchen, Xu, Shiqiang, Xia, Liliang, Duan, Huangqi, Wang, Shujun, Ji, Ping, Huang, Weiren, Zhao, Guoping, Cao, Zhiwei, Shen, Haibo, Wang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734250/ https://www.ncbi.nlm.nih.gov/pubmed/33329543 http://dx.doi.org/10.3389/fimmu.2020.576603 |
Ejemplares similares
-
Peripheral tuberculin purified protein derivative specific T cell immunoreactivity dynamics in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin instillation treatment
por: Duan, Huangqi, et al.
Publicado: (2022) -
LGALS4 as a Prognostic Factor in Urothelial Carcinoma of Bladder
Affects Cell Functions
por: Ding, Yu, et al.
Publicado: (2019) -
Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line
por: Wang, Chen, et al.
Publicado: (2023) -
Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
por: Zhang, Shun, et al.
Publicado: (2021) -
Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis
por: Zhang, Shun, et al.
Publicado: (2022)